Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
Joette Gdovin Bergeson, PhD
Advertisement
Articles by Joette Gdovin Bergeson, PhD
Advertisement
Latest Updated Articles
- US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus
Published: February 11th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
2
November 2025 Pharmacy Policy Updates
3
Recapping TMS 2025: Evolving Insights and Future Directions in Menopause Care
4
Improving Disaster Preparedness and Reaction in a Community Medical Center Pharmacy Through Gamification
5
